Clinical outcomes of online adaptive RT and conventional RT for muscle invasive bladder cancer.

被引：0
|
作者：
Yeh, J. [1 ]
Foroudi, F. [2 ]
Tai, K. H. [1 ]
Bressel, M. [1 ]
Kron, T. [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Radiat Oncol, Melbourne, Vic, Australia
[2] Austin Hlth, Olivia Newton John Canc Wellness & Res Ctr, Radiat Oncol, Melbourne, Vic, Australia
来源：
RADIOTHERAPY AND ONCOLOGY | 2021年 / 161卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD-0851
引用
收藏
页码：S685 / S685
页数：1
相关论文
共 50 条
  • [21] Treatment target development in muscle-invasive bladder cancer.
    Brown, Mick D.
    Robinson, Richard
    Hart, Claire
    Clarke, Noel W.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [22] Kent experience of radical chemoradiotherapy for muscle invasive bladder cancer.
    Gough, Jessica
    Sridharan, Mathini
    Li, Ruochen
    Raman, Rakesh
    Edwards, Albert
    Clarke, Amanda
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [23] Development of a real-time RT-PCR clinical test for survivin-based detection of bladder cancer.
    Heaney, DL
    Moussa, O
    Keane, T
    Wolff, DJ
    Watson, DK
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2005, 7 (05): : 683 - 683
  • [24] Bladder cancer susceptibility polymorphisms and mortality from non-muscle and muscle-invasive bladder cancer.
    Leeming, Reno C.
    Zens, Michael S.
    Seigne, John D.
    Christensen, Brock C.
    Gilbert-Diamond, Diane
    Karagas, Margaret R.
    Passarelli, Michael N.
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 54 - 55
  • [25] Outcomes of elderly patients with muscle invasive bladder cancer (MIBC) treated with cystectomy or radiation therapy (RT): A surveillance epidemiology and end results (SEER) database analysis
    Tripathi, Abhishek
    Friderici, Jennifer
    Preston, Mark A.
    Trinh, Quoc-Dien
    Mouw, Kent
    Beard, Clair
    Bellmunt, Joaquim
    Stewart, James A.
    Kibel, Adam S.
    Harshman, Lauren Christine
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] Clinical Outcomes of Primary Versus Secondary Non-muscle Invasive Bladder Cancer
    Tseng, Y.
    Chung, S.
    UROLOGY, 2012, 80 (03) : S211 - S211
  • [27] Oncologic outcomes of complete transurethral resection prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Pak, Jamie Sungmin
    Haas, Christopher R.
    Reyes, Helena Vila
    Anderson, Christopher B.
    DeCastro, Guarionex Joel
    Benson, Mitchell C.
    McKiernan, James M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Radiotherapy or cystectomy in muscle-invasive bladder cancer: Outcomes with two clinical pathways
    Maitre, Priyamvada
    Kashid, Sheetal
    Guleja, Ajit
    Arora, Amandeep
    Joshi, Amit
    Pal, Mahendra
    Bakshi, Ganesh
    Menon, Santosh
    Katdare, Aparna
    Prakash, Gagan
    Murthy, Vedang
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2523 - S2525
  • [29] Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer
    K. M. Patel
    K. E. van der Vos
    C. G. Smith
    F. Mouliere
    D. Tsui
    J. Morris
    D. Chandrananda
    F. Marass
    D. van den Broek
    D. E. Neal
    V. J. Gnanapragasam
    T. Forshew
    B. W. van Rhijn
    C. E. Massie
    N. Rosenfeld
    M. S. van der Heijden
    Scientific Reports, 7
  • [30] Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer
    Patel, K. M.
    van der Vos, K. E.
    Smith, C. G.
    Mouliere, F.
    Tsui, D.
    Morris, J.
    Chandrananda, D.
    Marass, F.
    van den Broek, D.
    Neal, D. E.
    Gnanapragasam, V. J.
    Forshew, T.
    van Rhijn, B. W.
    Massie, C. E.
    Rosenfeld, N.
    van der Heijden, M. S.
    SCIENTIFIC REPORTS, 2017, 7
12345